Kimberly-Clark Stock - Analyst consensus and defensive appeal

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 10:30 UTC. Details in the imprint.

Kimberly-Clark (US4943681035) is a staple of the US consumer sector and a long-standing member of the Standard & Poor's 500 index. With no fresh company news from major wires or investor relations today, the focus shifts to how the market values the stock and what analysts expect.

What consensus data shows

Major business wires such as Reuters, Bloomberg and the Wall Street Journal did not carry fresh Kimberly-Clark-specific headlines in the past 24 hours, nor did the company's investor relations feed publish a new ad-hoc update in that period.

Market data aggregators show Kimberly-Clark shares recently changing hands at around $102 on the New York Stock Exchange, corresponding to a market capitalization of roughly $34 billion and a trailing price-earnings ratio near 16.

Analyst stance on the stock

Consensus snapshots from financial data platforms point to an overall Hold stance on Kimberly-Clark, with the average analyst rating typically sitting between Neutral and Equal Weight on most services tracking the stock.

According to one such snapshot, the mean 12-month price target clusters in the low- to mid-teens above the last closing price, implying modest expected upside but no strong conviction call in either direction from the analyst community.

How the company makes money

Kimberly-Clark generates its revenue primarily from branded tissue and personal care products, including consumer names such as Kleenex tissues, Huggies diapers and Kotex feminine hygiene products, sold globally through retail and professional channels.

Where the stock trades today

Kimberly-Clark shares trade on the New York Stock Exchange under the ticker KMB at $102.56 as of 06/18/2026, 16:00 ET.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.